nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—SLC22A2—Cytarabine—lymphatic system cancer	0.333	0.755	CbGbCtD
Memantine—CYP2C19—Teniposide—lymphatic system cancer	0.108	0.245	CbGbCtD
Memantine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000478	0.000855	CcSEcCtD
Memantine—Tremor—Carmustine—lymphatic system cancer	0.000477	0.000853	CcSEcCtD
Memantine—Oedema—Bleomycin—lymphatic system cancer	0.000476	0.000851	CcSEcCtD
Memantine—Infection—Bleomycin—lymphatic system cancer	0.000473	0.000846	CcSEcCtD
Memantine—Anaemia—Carmustine—lymphatic system cancer	0.00047	0.000842	CcSEcCtD
Memantine—Back pain—Vincristine—lymphatic system cancer	0.00047	0.000841	CcSEcCtD
Memantine—Vomiting—Teniposide—lymphatic system cancer	0.000469	0.00084	CcSEcCtD
Memantine—Sepsis—Methotrexate—lymphatic system cancer	0.000468	0.000837	CcSEcCtD
Memantine—Agitation—Carmustine—lymphatic system cancer	0.000467	0.000837	CcSEcCtD
Memantine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000466	0.000834	CcSEcCtD
Memantine—Asthenia—Fludarabine—lymphatic system cancer	0.000465	0.000833	CcSEcCtD
Memantine—Rash—Teniposide—lymphatic system cancer	0.000465	0.000833	CcSEcCtD
Memantine—Dermatitis—Teniposide—lymphatic system cancer	0.000465	0.000832	CcSEcCtD
Memantine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000463	0.000829	CcSEcCtD
Memantine—Headache—Teniposide—lymphatic system cancer	0.000462	0.000828	CcSEcCtD
Memantine—Pruritus—Fludarabine—lymphatic system cancer	0.000459	0.000821	CcSEcCtD
Memantine—Back pain—Mitoxantrone—lymphatic system cancer	0.000457	0.000819	CcSEcCtD
Memantine—Leukopenia—Carmustine—lymphatic system cancer	0.000455	0.000815	CcSEcCtD
Memantine—Anorexia—Bleomycin—lymphatic system cancer	0.000453	0.000812	CcSEcCtD
Memantine—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000452	0.000809	CcSEcCtD
Memantine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00045	0.000805	CcSEcCtD
Memantine—Anaemia—Vincristine—lymphatic system cancer	0.000449	0.000803	CcSEcCtD
Memantine—Agitation—Vincristine—lymphatic system cancer	0.000446	0.000799	CcSEcCtD
Memantine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000446	0.000798	CcSEcCtD
Memantine—Polyuria—Methotrexate—lymphatic system cancer	0.000446	0.000798	CcSEcCtD
Memantine—Hypotension—Bleomycin—lymphatic system cancer	0.000444	0.000796	CcSEcCtD
Memantine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000444	0.000794	CcSEcCtD
Memantine—Convulsion—Carmustine—lymphatic system cancer	0.000441	0.000789	CcSEcCtD
Memantine—Hypertension—Carmustine—lymphatic system cancer	0.000439	0.000786	CcSEcCtD
Memantine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000439	0.000785	CcSEcCtD
Memantine—Nausea—Teniposide—lymphatic system cancer	0.000438	0.000785	CcSEcCtD
Memantine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000437	0.000782	CcSEcCtD
Memantine—Vertigo—Vincristine—lymphatic system cancer	0.000436	0.000781	CcSEcCtD
Memantine—Hepatic failure—Methotrexate—lymphatic system cancer	0.000435	0.000779	CcSEcCtD
Memantine—Leukopenia—Vincristine—lymphatic system cancer	0.000435	0.000778	CcSEcCtD
Memantine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000433	0.000776	CcSEcCtD
Memantine—Chest pain—Carmustine—lymphatic system cancer	0.000433	0.000775	CcSEcCtD
Memantine—Myalgia—Carmustine—lymphatic system cancer	0.000433	0.000775	CcSEcCtD
Memantine—Anxiety—Carmustine—lymphatic system cancer	0.000432	0.000773	CcSEcCtD
Memantine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000427	0.000764	CcSEcCtD
Memantine—Malaise—Mitoxantrone—lymphatic system cancer	0.000426	0.000763	CcSEcCtD
Memantine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000424	0.000759	CcSEcCtD
Memantine—Renal failure acute—Methotrexate—lymphatic system cancer	0.000424	0.000759	CcSEcCtD
Memantine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000423	0.000758	CcSEcCtD
Memantine—Convulsion—Vincristine—lymphatic system cancer	0.000421	0.000753	CcSEcCtD
Memantine—Hypertension—Vincristine—lymphatic system cancer	0.000419	0.00075	CcSEcCtD
Memantine—Confusional state—Carmustine—lymphatic system cancer	0.000419	0.000749	CcSEcCtD
Memantine—Oedema—Carmustine—lymphatic system cancer	0.000415	0.000743	CcSEcCtD
Memantine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000413	0.00074	CcSEcCtD
Memantine—Myalgia—Vincristine—lymphatic system cancer	0.000413	0.00074	CcSEcCtD
Memantine—Cough—Mitoxantrone—lymphatic system cancer	0.000413	0.000739	CcSEcCtD
Memantine—Infection—Carmustine—lymphatic system cancer	0.000412	0.000738	CcSEcCtD
Memantine—Vomiting—Fludarabine—lymphatic system cancer	0.000412	0.000738	CcSEcCtD
Memantine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00041	0.000733	CcSEcCtD
Memantine—Rash—Fludarabine—lymphatic system cancer	0.000409	0.000732	CcSEcCtD
Memantine—Dermatitis—Fludarabine—lymphatic system cancer	0.000409	0.000731	CcSEcCtD
Memantine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000408	0.000731	CcSEcCtD
Memantine—Pain—Bleomycin—lymphatic system cancer	0.000407	0.000728	CcSEcCtD
Memantine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000407	0.000728	CcSEcCtD
Memantine—Headache—Fludarabine—lymphatic system cancer	0.000406	0.000727	CcSEcCtD
Memantine—Tachycardia—Carmustine—lymphatic system cancer	0.000405	0.000725	CcSEcCtD
Memantine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000403	0.000721	CcSEcCtD
Memantine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000403	0.000721	CcSEcCtD
Memantine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000403	0.000721	CcSEcCtD
Memantine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000401	0.000718	CcSEcCtD
Memantine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000399	0.000715	CcSEcCtD
Memantine—Lethargy—Methotrexate—lymphatic system cancer	0.000399	0.000715	CcSEcCtD
Memantine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000398	0.000712	CcSEcCtD
Memantine—Oedema—Vincristine—lymphatic system cancer	0.000396	0.000709	CcSEcCtD
Memantine—Anorexia—Carmustine—lymphatic system cancer	0.000396	0.000708	CcSEcCtD
Memantine—Infection—Vincristine—lymphatic system cancer	0.000394	0.000705	CcSEcCtD
Memantine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000392	0.000702	CcSEcCtD
Memantine—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000391	0.0007	CcSEcCtD
Memantine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000389	0.000697	CcSEcCtD
Memantine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000389	0.000696	CcSEcCtD
Memantine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000388	0.000695	CcSEcCtD
Memantine—Hypotension—Carmustine—lymphatic system cancer	0.000388	0.000694	CcSEcCtD
Memantine—Oedema—Mitoxantrone—lymphatic system cancer	0.000386	0.000691	CcSEcCtD
Memantine—Nausea—Fludarabine—lymphatic system cancer	0.000385	0.00069	CcSEcCtD
Memantine—Infection—Mitoxantrone—lymphatic system cancer	0.000383	0.000686	CcSEcCtD
Memantine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000383	0.000686	CcSEcCtD
Memantine—Shock—Mitoxantrone—lymphatic system cancer	0.00038	0.00068	CcSEcCtD
Memantine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000378	0.000677	CcSEcCtD
Memantine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000378	0.000676	CcSEcCtD
Memantine—Urticaria—Bleomycin—lymphatic system cancer	0.000378	0.000676	CcSEcCtD
Memantine—Anorexia—Vincristine—lymphatic system cancer	0.000378	0.000676	CcSEcCtD
Memantine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000377	0.000674	CcSEcCtD
Memantine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000376	0.000673	CcSEcCtD
Memantine—Insomnia—Carmustine—lymphatic system cancer	0.000376	0.000672	CcSEcCtD
Memantine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000375	0.000671	CcSEcCtD
Memantine—Irritability—Methotrexate—lymphatic system cancer	0.000373	0.000668	CcSEcCtD
Memantine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000373	0.000668	CcSEcCtD
Memantine—Paraesthesia—Carmustine—lymphatic system cancer	0.000373	0.000667	CcSEcCtD
Memantine—Mood swings—Methotrexate—lymphatic system cancer	0.000371	0.000663	CcSEcCtD
Memantine—Hypotension—Vincristine—lymphatic system cancer	0.00037	0.000663	CcSEcCtD
Memantine—Dyspnoea—Carmustine—lymphatic system cancer	0.00037	0.000663	CcSEcCtD
Memantine—Somnolence—Carmustine—lymphatic system cancer	0.000369	0.000661	CcSEcCtD
Memantine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000368	0.000659	CcSEcCtD
Memantine—Ataxia—Methotrexate—lymphatic system cancer	0.000368	0.000659	CcSEcCtD
Memantine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000361	0.000647	CcSEcCtD
Memantine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000361	0.000646	CcSEcCtD
Memantine—Decreased appetite—Carmustine—lymphatic system cancer	0.000361	0.000646	CcSEcCtD
Memantine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000361	0.000646	CcSEcCtD
Memantine—Insomnia—Vincristine—lymphatic system cancer	0.000358	0.000642	CcSEcCtD
Memantine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000358	0.000642	CcSEcCtD
Memantine—Paraesthesia—Vincristine—lymphatic system cancer	0.000356	0.000637	CcSEcCtD
Memantine—Pain—Carmustine—lymphatic system cancer	0.000355	0.000635	CcSEcCtD
Memantine—Constipation—Carmustine—lymphatic system cancer	0.000355	0.000635	CcSEcCtD
Memantine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000352	0.000629	CcSEcCtD
Memantine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00035	0.000627	CcSEcCtD
Memantine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000347	0.00062	CcSEcCtD
Memantine—Decreased appetite—Vincristine—lymphatic system cancer	0.000345	0.000617	CcSEcCtD
Memantine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000344	0.000616	CcSEcCtD
Memantine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000343	0.000614	CcSEcCtD
Memantine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000342	0.000612	CcSEcCtD
Memantine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000342	0.000612	CcSEcCtD
Memantine—Fatigue—Vincristine—lymphatic system cancer	0.000342	0.000612	CcSEcCtD
Memantine—Asthenia—Bleomycin—lymphatic system cancer	0.000341	0.000611	CcSEcCtD
Memantine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00034	0.000608	CcSEcCtD
Memantine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00034	0.000608	CcSEcCtD
Memantine—Constipation—Vincristine—lymphatic system cancer	0.000339	0.000607	CcSEcCtD
Memantine—Pain—Vincristine—lymphatic system cancer	0.000339	0.000607	CcSEcCtD
Memantine—Asthma—Methotrexate—lymphatic system cancer	0.000338	0.000605	CcSEcCtD
Memantine—Pruritus—Bleomycin—lymphatic system cancer	0.000337	0.000602	CcSEcCtD
Memantine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000336	0.000601	CcSEcCtD
Memantine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000333	0.000596	CcSEcCtD
Memantine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000332	0.000593	CcSEcCtD
Memantine—Pain—Mitoxantrone—lymphatic system cancer	0.00033	0.000591	CcSEcCtD
Memantine—Constipation—Mitoxantrone—lymphatic system cancer	0.00033	0.000591	CcSEcCtD
Memantine—Abdominal pain—Carmustine—lymphatic system cancer	0.000328	0.000587	CcSEcCtD
Memantine—Body temperature increased—Carmustine—lymphatic system cancer	0.000328	0.000587	CcSEcCtD
Memantine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000324	0.00058	CcSEcCtD
Memantine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000321	0.000575	CcSEcCtD
Memantine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000318	0.000569	CcSEcCtD
Memantine—Dysuria—Methotrexate—lymphatic system cancer	0.000316	0.000566	CcSEcCtD
Memantine—Neutropenia—Methotrexate—lymphatic system cancer	0.000316	0.000566	CcSEcCtD
Memantine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000316	0.000565	CcSEcCtD
Memantine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000314	0.000563	CcSEcCtD
Memantine—Body temperature increased—Vincristine—lymphatic system cancer	0.000313	0.000561	CcSEcCtD
Memantine—Abdominal pain—Vincristine—lymphatic system cancer	0.000313	0.000561	CcSEcCtD
Memantine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000311	0.000557	CcSEcCtD
Memantine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000307	0.000549	CcSEcCtD
Memantine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000306	0.000548	CcSEcCtD
Memantine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000305	0.000546	CcSEcCtD
Memantine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000305	0.000546	CcSEcCtD
Memantine—Pneumonia—Methotrexate—lymphatic system cancer	0.000303	0.000543	CcSEcCtD
Memantine—Vomiting—Bleomycin—lymphatic system cancer	0.000302	0.000541	CcSEcCtD
Memantine—Infestation NOS—Methotrexate—lymphatic system cancer	0.000302	0.00054	CcSEcCtD
Memantine—Infestation—Methotrexate—lymphatic system cancer	0.000302	0.00054	CcSEcCtD
Memantine—Depression—Methotrexate—lymphatic system cancer	0.000301	0.000538	CcSEcCtD
Memantine—Rash—Bleomycin—lymphatic system cancer	0.0003	0.000537	CcSEcCtD
Memantine—Dermatitis—Bleomycin—lymphatic system cancer	0.0003	0.000536	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000299	0.000535	CcSEcCtD
Memantine—Asthenia—Carmustine—lymphatic system cancer	0.000298	0.000533	CcSEcCtD
Memantine—Renal failure—Methotrexate—lymphatic system cancer	0.000296	0.000531	CcSEcCtD
Memantine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000293	0.000525	CcSEcCtD
Memantine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000292	0.000523	CcSEcCtD
Memantine—Haematuria—Methotrexate—lymphatic system cancer	0.000287	0.000515	CcSEcCtD
Memantine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000285	0.00051	CcSEcCtD
Memantine—Epistaxis—Methotrexate—lymphatic system cancer	0.000284	0.000509	CcSEcCtD
Memantine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000284	0.000509	CcSEcCtD
Memantine—Asthenia—Vincristine—lymphatic system cancer	0.000284	0.000509	CcSEcCtD
Memantine—Diarrhoea—Carmustine—lymphatic system cancer	0.000284	0.000508	CcSEcCtD
Memantine—Nausea—Bleomycin—lymphatic system cancer	0.000283	0.000506	CcSEcCtD
Memantine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000281	0.000504	CcSEcCtD
Memantine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000277	0.000496	CcSEcCtD
Memantine—Dizziness—Carmustine—lymphatic system cancer	0.000275	0.000491	CcSEcCtD
Memantine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000272	0.000487	CcSEcCtD
Memantine—Diarrhoea—Vincristine—lymphatic system cancer	0.000271	0.000485	CcSEcCtD
Memantine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000271	0.000484	CcSEcCtD
Memantine—Hepatitis—Methotrexate—lymphatic system cancer	0.000271	0.000484	CcSEcCtD
Memantine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000269	0.000481	CcSEcCtD
Memantine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000267	0.000478	CcSEcCtD
Memantine—Urethral disorder—Methotrexate—lymphatic system cancer	0.000265	0.000475	CcSEcCtD
Memantine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000264	0.000473	CcSEcCtD
Memantine—Vomiting—Carmustine—lymphatic system cancer	0.000264	0.000472	CcSEcCtD
Memantine—Dizziness—Vincristine—lymphatic system cancer	0.000262	0.000469	CcSEcCtD
Memantine—Rash—Carmustine—lymphatic system cancer	0.000262	0.000469	CcSEcCtD
Memantine—Dermatitis—Carmustine—lymphatic system cancer	0.000262	0.000468	CcSEcCtD
Memantine—Visual impairment—Methotrexate—lymphatic system cancer	0.000261	0.000467	CcSEcCtD
Memantine—Headache—Carmustine—lymphatic system cancer	0.00026	0.000466	CcSEcCtD
Memantine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000256	0.000458	CcSEcCtD
Memantine—Eye disorder—Methotrexate—lymphatic system cancer	0.000253	0.000453	CcSEcCtD
Memantine—Tinnitus—Methotrexate—lymphatic system cancer	0.000252	0.000452	CcSEcCtD
Memantine—Vomiting—Vincristine—lymphatic system cancer	0.000252	0.000451	CcSEcCtD
Memantine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000251	0.00045	CcSEcCtD
Memantine—Rash—Vincristine—lymphatic system cancer	0.00025	0.000447	CcSEcCtD
Memantine—Dermatitis—Vincristine—lymphatic system cancer	0.00025	0.000447	CcSEcCtD
Memantine—Headache—Vincristine—lymphatic system cancer	0.000248	0.000444	CcSEcCtD
Memantine—Nausea—Carmustine—lymphatic system cancer	0.000247	0.000441	CcSEcCtD
Memantine—Angiopathy—Methotrexate—lymphatic system cancer	0.000246	0.00044	CcSEcCtD
Memantine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000245	0.000439	CcSEcCtD
Memantine—Immune system disorder—Methotrexate—lymphatic system cancer	0.000244	0.000438	CcSEcCtD
Memantine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000244	0.000437	CcSEcCtD
Memantine—Rash—Mitoxantrone—lymphatic system cancer	0.000243	0.000436	CcSEcCtD
Memantine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000243	0.000435	CcSEcCtD
Memantine—Chills—Methotrexate—lymphatic system cancer	0.000243	0.000435	CcSEcCtD
Memantine—Headache—Mitoxantrone—lymphatic system cancer	0.000242	0.000433	CcSEcCtD
Memantine—Alopecia—Methotrexate—lymphatic system cancer	0.000239	0.000428	CcSEcCtD
Memantine—Mental disorder—Methotrexate—lymphatic system cancer	0.000237	0.000424	CcSEcCtD
Memantine—Malnutrition—Methotrexate—lymphatic system cancer	0.000236	0.000422	CcSEcCtD
Memantine—Nausea—Vincristine—lymphatic system cancer	0.000235	0.000421	CcSEcCtD
Memantine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000231	0.000413	CcSEcCtD
Memantine—Nausea—Mitoxantrone—lymphatic system cancer	0.000229	0.00041	CcSEcCtD
Memantine—Back pain—Methotrexate—lymphatic system cancer	0.000228	0.000408	CcSEcCtD
Memantine—Vision blurred—Methotrexate—lymphatic system cancer	0.000222	0.000397	CcSEcCtD
Memantine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000219	0.000391	CcSEcCtD
Memantine—Anaemia—Methotrexate—lymphatic system cancer	0.000218	0.00039	CcSEcCtD
Memantine—Malaise—Methotrexate—lymphatic system cancer	0.000212	0.00038	CcSEcCtD
Memantine—Vertigo—Methotrexate—lymphatic system cancer	0.000212	0.000379	CcSEcCtD
Memantine—Leukopenia—Methotrexate—lymphatic system cancer	0.000211	0.000378	CcSEcCtD
Memantine—Cough—Methotrexate—lymphatic system cancer	0.000206	0.000368	CcSEcCtD
Memantine—Convulsion—Methotrexate—lymphatic system cancer	0.000204	0.000365	CcSEcCtD
Memantine—Arthralgia—Methotrexate—lymphatic system cancer	0.000201	0.000359	CcSEcCtD
Memantine—Myalgia—Methotrexate—lymphatic system cancer	0.000201	0.000359	CcSEcCtD
Memantine—Chest pain—Methotrexate—lymphatic system cancer	0.000201	0.000359	CcSEcCtD
Memantine—Discomfort—Methotrexate—lymphatic system cancer	0.000198	0.000355	CcSEcCtD
Memantine—Confusional state—Methotrexate—lymphatic system cancer	0.000194	0.000347	CcSEcCtD
Memantine—Infection—Methotrexate—lymphatic system cancer	0.000191	0.000342	CcSEcCtD
Memantine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000189	0.000338	CcSEcCtD
Memantine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000188	0.000337	CcSEcCtD
Memantine—Skin disorder—Methotrexate—lymphatic system cancer	0.000187	0.000334	CcSEcCtD
Memantine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000186	0.000333	CcSEcCtD
Memantine—Anorexia—Methotrexate—lymphatic system cancer	0.000183	0.000328	CcSEcCtD
Memantine—Hypotension—Methotrexate—lymphatic system cancer	0.00018	0.000322	CcSEcCtD
Memantine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000175	0.000314	CcSEcCtD
Memantine—Insomnia—Methotrexate—lymphatic system cancer	0.000174	0.000311	CcSEcCtD
Memantine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000173	0.000309	CcSEcCtD
Memantine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000171	0.000307	CcSEcCtD
Memantine—Somnolence—Methotrexate—lymphatic system cancer	0.000171	0.000306	CcSEcCtD
Memantine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000169	0.000303	CcSEcCtD
Memantine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000167	0.000299	CcSEcCtD
Memantine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000166	0.000297	CcSEcCtD
Memantine—Fatigue—Methotrexate—lymphatic system cancer	0.000166	0.000297	CcSEcCtD
Memantine—Pain—Methotrexate—lymphatic system cancer	0.000164	0.000294	CcSEcCtD
Memantine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000158	0.000284	CcSEcCtD
Memantine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000157	0.000281	CcSEcCtD
Memantine—Urticaria—Methotrexate—lymphatic system cancer	0.000153	0.000273	CcSEcCtD
Memantine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000152	0.000272	CcSEcCtD
Memantine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000152	0.000272	CcSEcCtD
Memantine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000142	0.000254	CcSEcCtD
Memantine—Asthenia—Methotrexate—lymphatic system cancer	0.000138	0.000247	CcSEcCtD
Memantine—Pruritus—Methotrexate—lymphatic system cancer	0.000136	0.000244	CcSEcCtD
Memantine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000132	0.000236	CcSEcCtD
Memantine—Dizziness—Methotrexate—lymphatic system cancer	0.000127	0.000228	CcSEcCtD
Memantine—Vomiting—Methotrexate—lymphatic system cancer	0.000122	0.000219	CcSEcCtD
Memantine—Rash—Methotrexate—lymphatic system cancer	0.000121	0.000217	CcSEcCtD
Memantine—Dermatitis—Methotrexate—lymphatic system cancer	0.000121	0.000217	CcSEcCtD
Memantine—Headache—Methotrexate—lymphatic system cancer	0.00012	0.000216	CcSEcCtD
Memantine—Nausea—Methotrexate—lymphatic system cancer	0.000114	0.000204	CcSEcCtD
